Publikasi

EMA’s CHMP grants PRIME status to AbelZeta’s C-CAR168

An autologous anti-cluster of differentiation 20/B-cell maturation antigen (CD20...

From vision to execution: How Piyush Das is driving the...

Leadership is often measured by numbers—market growth, business expansion, and ...

Merck CATALYST – NMIMS SPPSPTM Program to prepare futur...

Reinforcing their shared commitment to advancing industry-integrated education,...

Standard Chartered and Dr. Reddy’s Foundation extend pa...

Standard Chartered and Dr. Reddy’s Foundation (DRF) today announced the extensi...

Glenmark receives US FDA approval to expand the use of ...

Glenmark Specialty S.A. (Glenmark) announced that US FDA has approved the expan...

CDSCO proposes to ban “Same Brand, Different Drug” prac...

Regulator introduces “One Brand – One Formulation” policy to improve patient sa...

GANZ® powered by CBC receives STQC certification

GANZ® surveillance product range, powered by CBC, has  achieved STQC Essential ...

Lupin spins out two oncology programs to Kaveri Therape...

Global pharma major Lupin, announced the strategic spin-out of two oncology pro...

Early Genomic Indicators of Praziquantel Resistance in ...

Schistosomiasis affects more than 250 million people worldwide, with 90% of infe...

Flu Virus Interaction with Host Cell Machinery Mapped I...

Researchers developed a customized experimental workflow combining cross-linking...

Memory Shaped by Brain Remodeling During Adolescence in...

Protective mesh-like structures, called perineuronal nets, stabilize memory circ...

Patient-Derived Tumor Organoids Show Promise for Person...

Researchers developed a 220-sample pan-cancer patient-derived organoid platform ...

Protein Protects Against Tau Tangles, Synaptic Loss in ...

Scientists found that upregulating a protein known as SORLA offers protection ag...

The Family Business: The Dumesics

A Father and Son Who Share More than a Name It is definitely “like father, like ...

New €25 Million BioReliance Testing Facility Opens at M...

The 2,000-square-meter BioReliance facility in Darmstadt, Germany, will also off...

Samsung Biologics to acquire PolyPeptide in $1.81bn cas...

The proposed offer is set at SFr44.31 per share for 100% of PolyPeptide’s fully ...